• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

临床输血与检验 ›› 2026, Vol. 28 ›› Issue (5): 740-747.DOI: 10.3969/j.issn.1671-2587.2026.05.011

• 临床输血 • 上一篇    下一篇

意外抗体筛查阳性患者的DAT分型及Rh表型与抗体鉴定结果的关联

薛金丹, 刘佳艺, 崔蕊, 陈鹏飞, 顾海慧   

  1. 海军军医大学第一附属医院输血科,上海 200433
  • 收稿日期:2026-09-02 修回日期:2026-09-23 出版日期:2026-10-20 发布日期:2026-11-11
  • 通讯作者: 顾海慧,主要从事临床输血与细胞治疗研究,(E-mail)haihuigu@126.com。
  • 作者简介:薛金丹,主要从事血型血清学与临床输血研究,(E-mail)xuejindan00@163.com。并列第一作者:刘佳艺,主要从事血型血清学检测研究,(E-mail)957572309@qq.com。

Association of Direct Antiglobulin Test Patterns and Rh Phenotypes with Unexpected Antibody Identification Outcomes

XUE Jindan, LIU Jiayi, CUI Rui, CHEN Pengfei, GU Haihui   

  1. Department of Transfusion Medicine, The First Affiliated Hospital of Naval Medical University, Shanghai 200433
  • Received:2026-09-02 Revised:2026-09-23 Online:2026-10-20 Published:2026-11-11

摘要: 目的 探讨意外抗体筛查阳性患者不同直接抗人球蛋白试验(DAT)结果分型及Rh表型与抗体鉴定未确定特异性的关系,为复杂抗体鉴定流程提供早期识别依据。方法 回顾性收集2023年1月—2026年6月本院445例意外抗体筛查阳性患者的临床资料,所有患者均完成抗体鉴定、DAT和Rh分型,同一患者仅保留首次符合条件的记录。DAT分为阴性、IgG单独型和含C3d型。以抗体鉴定未确定特异性为主要结局,采用单因素和多因素Logistic回归分析相关因素,建立临床模型、临床+Rh模型和临床+Rh+DAT模型。结果 445例患者中,148例(33.3%)未能明确抗体特异性。DAT阴性、IgG单独型和含C3d型患者的未明确率分别为21.9%(63/288)、39.4%(28/71)和66.3%(57/86)(P<0.001)。校正临床疾病类别和Rh表型后,以DAT阴性为参照,IgG单独型和含C3d型患者抗体特异性未明确的可能性仍较高,校正比值比(adjusted odds ratio,aOR)分别为2.020(95%CI:1.106—3.686)和6.440(95%CI:3.603—11.512)。CcDEe表型亦与结局相关(aOR=3.251,95%CI:1.909—5.537)。161例Rh系统抗体患者中,148例(91.9%)表型—抗体一致,13例(8.1%)不一致;后者DAT阳性率高于前者(61.5% vs 26.4%,P=0.021)。3个模型的受试者工作特征曲线下面积(area under the receiver operating characteristic curve, AUROC)依次为0.651、0.703和0.770,相邻模型比较均P<0.001。结论 意外抗体筛查阳性患者中,IgG单独型和含C3d型DAT均与抗体特异性未明确独立相关,其中含C3d型的关联更强。临床资料基础上依次加入Rh表型和DAT结果后,模型对抗体特异性未明确的区分能力逐步提高,可早期识别需要复杂鉴定的标本从而提高临床输血时效性。

关键词: 直接抗人球蛋白试验, 意外抗体, Rh表型, 抗体鉴定

Abstract: Objective To investigate the relationship of direct antiglobulin test (DAT) patterns and Rh phenotypes with undetermined specificity in antibody identification in patients with positive unexpected antibody screening results, thereby providing a basis for early recognition of specimens requiring complex antibody identification procedures. Methods Clinical data were retrospectively collected from 445 patients with positive unexpected antibody screening results at our hospital from January 2023 to June 2026. All patients underwent antibody identification, DAT, and Rh typing, and only the first eligible record was retained for each patient. DAT results were classified as negative, IgG-only, or C3d-containing. The primary outcome was undetermined specificity in antibody identification. Univariate and multivariable logistic regression analyses were performed, and clinical, clinical+Rh, and clinical+Rh+DAT models were developed. Results Among the 445 patients, antibody specificity could not be determined in 148 (33.3%). The rates of undetermined antibody specificity in patients with negative, IgG-only, and C3d-containing DAT results were 21.9% (63/288), 39.4% (28/71), and 66.3% (57/86), respectively (P<0.001). After adjustment for clinical disease category and Rh phenotype, the likelihood of undetermined antibody specificity remained higher in patients with IgG-only and C3d-containing DAT results than in DAT-negative patients, with adjusted odds ratios of 2.020 (95%CI: 1.106—3.686) and 6.440 (95%CI: 3.603—11.512), respectively. The CcDEe phenotype was also associated with the outcome (aOR=3.251, 95%CI: 1.909—5.537). Among 161 patients with Rh system antibodies, 148 (91.9%) showed phenotype-antibody concordance and 13 (8.1%) showed discordance; the DAT positivity rate was higher in the latter than in the former (61.5% vs 26.4%, P=0.021). The area under the receiver operating characteristic curve (AUROC) was 0.651, 0.703, and 0.770 for the three models, respectively, with P<0.001 for both adjacent-model comparisons. Conclusion Among patients with positive unexpected antibody screening results, both IgG-only and C3d-containing DAT results were independently associated with undetermined antibody specificity, with a stronger association for C3d-containing DAT results. After sequentially adding Rh phenotype and DAT results to the clinical data-based model, the model's ability to distinguish antibody specificity that was not clearly defined gradually improved, enabling early identification of specimens requiring complex identification and thereby improving the timeliness of clinical blood transfusion.

Key words: Direct antiglobulin test, Unexpected antibody, Rh phenotype, Antibody identification

中图分类号: